Enhancing the ability of autophagy and proliferation of bone marrow mesenchymal stem cells by interleukin-8 through Akt-STAT3 pathway in hypoxic environment

Lei Shen1 Shanqiang Zhang1 Xiaodong Zhang1 Yuting Zhang1 Liping Xie1 Yang Jiang1 Yong Ma1 Guofeng Li1

(1.Department of Anatomy, Qiqihar Medical School, Qiqihaer , Heilongjiang, China 161006)

【Abstract】To study the effects and mechanisms of interleukin-8 (IL-8) on the proliferation and autophagy of human bone marrow mesenchymal stem cells (hBMSC) under hypoxic condition. In the hypoxia model, we set the non-stimulated hBMSC as the hypoxia control group; the hBMSC stimulated by 100 μmol/L human IL-8 as the IL-8 group; the hBMSC stimulated by 50 μmol/L MK2206 (Akt protein inhibitor) and 100 μmol/L IL-8 as the Akt inhibitor group; and the normal cultured hBMSC as the normal control group. The experiments of EdU cell proliferation and TUNEL apoptosis were respectively used to detect the number of positive cells that were labeled by EdU and apoptosis in each group, and Western blotting and ELISA were used respectively to detect the expression of autophagy protein (LC-3), Akt/STAT3 and other proteins in each group. The results indicated that the proliferation and autophagy of hBMSC in IL-8 group was higher than that in hypoxia control group and Akt inhibitor group, and the apoptosis rate in IL-8 group decreased. These results and the high expression of Akt, STAT3 and VEGF protein of IL-8 group show that under the hypoxic condition, IL-8 played a protective role on MSC through the Akt-STAT3 pathway. It had important significance in the protection of MSC against the injury due to ischemia and hypoxia, and promoted the application of MSC in regenerative medicine.

【Keywords】 hypoxia; interleukin-8; mesenchymal stem cell; autophagy; Akt-STAT3 pathway;


【Funds】 National Natural Science Foundation of China (No. 81541137) National Natural Science Foundation of China(No.81541137)

Download this article

(Translated by ZHAO Bo)


    [1]Verges S, Chacaroun S, Godin-Ribuot D, et al. Hypoxic conditioning as a new therapeutic modality. Front Pediatr, 2015, 3:58.

    [2]Xiao HJ. The symbolic landmarks in the development of aviation oxygen supply equipment and protection physiology. Med J Chin PLA, 2004, 29(10):833–835 (in Chinese).

    [3]Jia SG, Liang H. Action and relationship of aerospace atmospheric environment medico-engineering. Acta Aeron Astronaut Sin, 2001, 22(5):390–395 (in Chinese).

    [4]Wang Y, Chen XD, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol, 2014, 15(11):1009–1016.

    [5]Buravkova LB, Andreeva ER, Gogvadze V, et al. Mesenchymal stem cells and hypoxia: where are we? Mitochondrion, 2014, 19:105–112.

    [6]Sun BK, Siprashvili Z, Khavari PA. Advances in skin grafting and treatment of cutaneous wounds. Science, 2014, 346(6212):941–945.

    [7]Qin CS, Li XY, Jiang XJ, et al. Micro-inflammatory state and calcification. Chin J Tissue Eng Res, 2015, 19(29):4721–4725(in Chinese).

    [8]Russo RC, Garcia CC, Teixeira MM, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol, 2014, 10(5):593–619.

    [9]Chen W, Wu YX, Li L, et al. Adenosine accelerates the healing of diabetic ischemic ulcers by improving autophagy of endothelial progenitor cells grown on a biomaterial. Sci Rep, 2015, 5:11594.

    [10]Shafagh M, Rahmani F, Delirezh N. Cu O nanoparticles induce cytotoxicity and apoptosis in human K562 cancer cell line via mitochondrial pathway, through reactive oxygen species and P53. Iran J Basic Med Sci, 2015, 18(10):993–1000.

    [11]Shen L, Zeng W, Wu YX, et al. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplant, 2013, 22(6):1011–1021.

    [12]Kim JY, Lee JS, Han YS, et al. Pretreatment with lycopene attenuates oxidative stress-induced apoptosis in human mesenchymal stem cells. Biomol Ther, 2015, 23(6):517–524.

    [13]Ma XW, Cui DP, Zhao DW. Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head. Int J Clin Exp Med, 2015, 8(9):15528–15534.

    [14]Liu LB, Xie F, Chang KK, et al. Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8. Int J Clin Exp Pathol, 2014, 7(2):575–583.

    [15]Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med, 2014, 6(265):265sr6.

    [16]Zhang P, Zhang XD, Jiang Y, et al. Effect of chemokine-8 factor on the migration ability of human adipose derived mesenchymal stem cell in high glucose environment. Acta Anat Sin, 2015, 46(6):764–771(in Chinese).

    [17]Liu JJ, Hao HJ, Huang H, et al. Hypoxia regulates the therapeutic potential of mesenchymal stem cells through enhanced autophagy. Int J Low Extrem Wounds, 2015, 14(1):63–72.

    [18]Bi LK, Zhou N, Liu C, et al. Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells. Urol Oncol, 2014, 32(5):607–612.

    [19]Piperi C, Samaras V, Levidou G, et al. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas:correlation with IL-6, VEGF and microvessel morphometry. Cytokine, 2011, 55(3):387–395.

    [20]Levidou G, Sachanas S, Pangalis GA, et al. Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance. Biomed Res Int, 2014, 2014:251479.

    [21]Hou Y, Ryu CH, Jun JA, et al. IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor. Cell Biol Int, 2014, 38(9):1050–1059.

    [22]Berendsen AD, Olsen BR. How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells. J Histochem Cytochem, 2014, 62(2):103–108.

    [23]Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol, 2015, 16(8):461–472.

    [24]Sun DQ, Sawada A, Nakashima M, et al. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. Urol Oncol, 2015, 33(3):111. e17–111. e26.

    [25]Mc Cubrey JA, Steelman LS, Chappell WH, et al. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. Oncotarget, 2012, 3(10):1068–1111.

    [26]García-Prat L, Martínez-Vicente M, Perdiguero E, et al. Autophagy maintains stemness by preventing senescence. Nature, 2016, 529(7584):37–42.

    [27]Wu JF, Niu J, Li XP, et al. Hypoxia induces autophagy of bone marrow-derived mesenchymal stem cells via activation of ERK1/2. Cell Physiol Biochem, 2014, 33(5):1467–1474.

    [28]Wu YS, Li Y, Zhang H, et al. Autophagy and m TORC1 regulate the stochastic phase of somatic cell reprogramming. Nat Cell Biol, 2015, 17(6):715–725.

    [29]Zhang Z, Chu G, Wu HX, et al. IL-8 reduces VCAM-1 secretion of smooth muscle cells by increasing p-ERK expression when 3-D co-cultured with vascular endothelial cells. Clin Invest Med, 2011, 34(3):E138–E146.

This Article


CN: 11-1998/Q

Vol 32, No. 10, Pages 1422-1432

October 2016


Article Outline



  • 1 Materials and methods
  • 2 Results and analysis
  • 3 Discussion
  • References